Highlands Oncology Group - Springdale
Springdale, Arkansas, United States
Cancer treatment center in Springdale, Arkansas
3901 Parkway Cir # 100, Springdale, AR 72762
About Highlands Oncology Group - Springdale
"Highlands Oncology is dedicated to providing the highest quality of innovative cancer care delivered with compassion and precision. With locations in Springdale, Fayetteville, and Rogers, we provide Northwest Arkansas with comprehensive cancer care."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
SWOG Cancer Research Network
4
CTI BioPharma
2
Alliance for Clinical Trials in Oncology
1
Ascentage Pharma Group Inc.
1
Calico Life Sciences LLC
1
Daiichi Sankyo, Inc.
1
Gritstone bio, Inc.
1
Hutchison Medipharma Limited
1
Mirati Therapeutics Inc.
1
Pfizer
1
Radiation Therapy Oncology Group
1
Clinical Trials at Highlands Oncology Group - Springdale
During the past decade, Highlands Oncology Group - Springdale conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
1999-10-15
2018-05-01
Completed
983
S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
2001-05-01
2012-02-01
Completed
399
Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
2001-02-01
2005-01-01
Terminated
Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer
2003-01-01
2004-10-01
Terminated
350
Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
2003-02-01
2013-11-01
Completed
265
S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
2004-01-01
2009-04-01
Completed
766
S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
2007-04-01
2011-07-01
Completed
62
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
2016-12-08
2023-02-15
Terminated
3,021
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Highlands Oncology Group - Springdale" #1 sponsor was "SWOG Cancer Research Network" with 4 trials, followed by "CTI BioPharma" with 2 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Ascentage Pharma Group Inc." with 1 trials sponsored and "Calico Life Sciences LLC"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Highlands Oncology Group - Springdale"
#1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "BeiGene" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Highlands Oncology Group - Springdale
According to Clinical.Site data, the most researched conditions in "Highlands Oncology Group - Springdale" are
"Endometrial Cancer" (2 trials), "Lung Cancer" (2 trials), "Pancreatic Cancer" (2 trials), "Prostate Cancer" (2 trials) and "Advanced Solid Tumors Cancer" (1 trials). Many other conditions were trialed in "Highlands Oncology Group - Springdale" in a lesser frequency.
Clinical Trials Intervention Types at Highlands Oncology Group - Springdale
Most popular intervention types in "Highlands Oncology Group - Springdale" are "Drug" (14 trials), "Biological" (4 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "ABBV-CLS-579" (1 trials), "APG-5918" (1 trials), "Aspirin" (1 trials), "Atezolizumab" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Highlands Oncology Group - Springdale
The vast majority of trials in "Highlands Oncology Group - Springdale" are
13 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Highlands Oncology Group - Springdale
Currently, there are NaN active trials in "Highlands Oncology Group - Springdale".
undefined are not yet recruiting,
6 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Highlands Oncology Group - Springdale,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Highlands Oncology Group - Springdale, 3 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".